Bundle includes

Here are all the products that are included in your bundle.

Learning Highlights

  • Complete Safety Reporting Framework

    See how definitions, PI oversight, reporting obligations, and unanticipated problems connect, so the whole process makes sense from the first adverse event to the IRB submission.

  • Built for U.S.-Regulated Site Practice

    Grounded in FDA regulations, ICH guidance, ISO standards, and Office for Human Research Protections (OHRP) expectations, written for how U.S. clinical trials run.

  • Decisions You Can Stand Behind

    Built to help you document clearly and hold up your end during audits, inspections, and IRB review.

Your Safety Reporting Foundation

All in One Place

Safety reporting is one of the responsibilities sites most often get tangled up in, and it's easy to see why. Definitions, oversight expectations, reporting timelines, and IRB requirements all live in separate places, so it's hard to see how they fit together when you've got a real event in front of you. This series pulls those pieces into one path built for U.S.-regulated trials. Across four short sessions, you'll learn how adverse events are defined across FDA, ICH, and ISO frameworks, how Principal Investigators evaluate and oversee safety events, how site teams decide what to report and to whom, and how unanticipated problems help you spot new risks to participants. Instead of treating each topic in isolation, the series shows how one decision leads to the next, from recognizing an adverse event, to weighing seriousness and relatedness, to documenting oversight, reporting it, and communicating with your IRB and sponsor. If you handle safety reporting at a site and want a clear foundation you can rely on, this is it.

Build your safety reporting foundation in one place.

Four short sessions, one clear path, priced so a whole site team can take them.

Buy Now